Every sector is being impacted by the rise of artificial intelligence. Venture capitalist John Flavin, Co-Founder and CEO of Portal Innovations, says he is using it to find the next biotech company to invest in. Flavin tells Asking for a Trend that his firm has developed an "AI-enabled platform that can predict innovation and start to rank innovative inventors coming out of universities." He points out that most new drugs start "on the bench at a university several years prior to it becoming a drug." Flavin wants to find those ideas and scientists early so he can be an early investor in their ventures.

Watch the video above to hear how some of the companies Flavin invested in are using AI.

For more expert insight and the latest market action, click here to watch this full episode of Asking for a Trend.

This post was written by Stephanie Mikulich.